Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Parkinson's Disease

Free Subscription Articles published in Brain Res Retrieve available abstracts of 50 articles: HTML format

Single Articles

June 2024
1. MA LY, Jia B, Geng H, Liang J, et al
   Poly(rC)-binding protein 1 alleviates neurotoxicity in 6-OHDA-induced SH-SY5Y cells and modulates glial cells in neuroinflammation.
   Brain Res. 2024;1832:148863.
   PubMed     Abstract available
   
   
   May 2024
2. LI L, Chen Z, Hao C
   Neuroprotective effects of polyphyllin VI against rotenone-induced toxicity in SH-SY5Y cells.
   Brain Res. 2024;1830:148824.
   PubMed     Abstract available
   
   
   April 2024
3. HOFFMEISTER JD, Broadfoot CK, Schaen-Heacock NE, Lechner SA, et al
   Vocal and tongue exercise in early to mid-stage Parkinson disease using the Pink1-/- rat.
   Brain Res. 2024 Apr 27:148958. doi: 10.1016/j.brainres.2024.148958.
   PubMed     Abstract available
   
   
   
4. CANSIZ D, Unal I, Gani Surmen M, Surmen S, et al
   Gentisic acid exerts neuroprotective effects in neurotoxin-induced Parkinson's disease model in zebrafish: Cross-talk between pathways related with neurodegeneration in the gut-brain axis.
   Brain Res. 2024 Apr 19:148952. doi: 10.1016/j.brainres.2024.148952.
   PubMed     Abstract available
   
   
   March 2024
5. ROSTAMI Z, Salari M, Mahdavi S, Etemadifar M, et al
   Abnormal multisensory temporal discrimination in Parkinson's disease.
   Brain Res. 2024 Mar 30:148901. doi: 10.1016/j.brainres.2024.148901.
   PubMed     Abstract available
   
   
   
6. MANSOUR HM, Mohamed AF, Khattab MM, El-Khatib AS, et al
   Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation of dopamine D3 receptor.
   Brain Res. 2024;1834:148893.
   PubMed     Abstract available
   
   
   
7. GENG C, Tan L, Chenchen
   Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias.
   Brain Res. 2024 Mar 20:148881. doi: 10.1016/j.brainres.2024.148881.
   PubMed     Abstract available
   
   
   December 2023
8. FLORES AJ, Bartlett MJ, Seaton BT, Samtani G, et al
   Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion.
   Brain Res. 2023;1821:148613.
   PubMed     Abstract available
   
   
   November 2023
9. SMIT RD, Ghosh B, Campion TJ 3rd, Stingel R, et al
   STAT3 protects dopaminergic neurons against degeneration in animal model of Parkinson's disease.
   Brain Res. 2023;1824:148691.
   PubMed     Abstract available
   
   
   
10. LIU X, Liu X, Liu Y, Yang B, et al
    Utility of serum neurofilament light chain and glial fibrillary acidic protein as diagnostic biomarkers of freezing of gait in Parkinson's disease.
    Brain Res. 2023;1822:148660.
    PubMed     Abstract available
    
    
    
11. ZHANG L, Guo Y, Liu J, Li L, et al
    Transcranial direct current stimulation of the prefrontal cortex improves depression-like behaviors in rats with Parkinson's disease.
    Brain Res. 2023 Nov 1:148649. doi: 10.1016/j.brainres.2023.148649.
    PubMed     Abstract available
    
    
    October 2023
12. ISMAEL S, Colvin RA, Lee D
    Activation of cyclic AMP signaling pathway in dopaminergic neurons rescues locomotion defects in a Drosophila larval model of Parkinson's disease.
    Brain Res. 2023 Oct 20:148641. doi: 10.1016/j.brainres.2023.148641.
    PubMed     Abstract available
    
    
    September 2023
13. YIN N, Wang H, Wang Z, Feng K, et al
    A study of brain networks associated with Freezing of gait in Parkinson's disease using transfer entropy analysis.
    Brain Res. 2023 Sep 30:148610. doi: 10.1016/j.brainres.2023.148610.
    PubMed     Abstract available
    
    
    
14. CABRAL LM, Oliveira LM, Miranda NC, Kawamoto EM, et al
    TNFR1-mediated neuroinflammation is necessary for respiratory deficits observed in 6-hydroxydopamine mouse model of Parkinsons Disease.
    Brain Res. 2023 Sep 25:148586. doi: 10.1016/j.brainres.2023.148586.
    PubMed     Abstract available
    
    
    
15. SONG J, Zhao Y, Shan X, Luo Y, et al
    Active ingredients of Chinese medicine with immunomodulatory properties: NF-kappaB pathway and Parkinson's disease.
    Brain Res. 2023 Sep 23:148603. doi: 10.1016/j.brainres.2023.148603.
    PubMed     Abstract available
    
    
    August 2023
16. UNAL I, Cansiz D, Beler M, Sezer Z, et al
    Sodium-dependent Glucose Co-Transporter-2 Inhibitor Empagliflozin Exerts Neuroprotective Effects in Rotenone-Induced Parkinson's Disease Model in Zebrafish; Mechanism Involving Ketogenesis and Autophagy.
    Brain Res. 2023 Aug 15:148536. doi: 10.1016/j.brainres.2023.148536.
    PubMed     Abstract available
    
    
    June 2023
17. KHOT M, Sood A, Pushpa Tryphena K, Pinjala P, et al
    Dimethyl fumarate ameliorates Parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis.
    Brain Res. 2023 Jun 12:148462. doi: 10.1016/j.brainres.2023.148462.
    PubMed     Abstract available
    
    
    
18. RAI P, Ratnaparkhi A, Kumar Roy J
    Rab11 rescues muscle degeneration and synaptic morphology in the park(13/+) Parkinson model of Drosophila melanogaster.
    Brain Res. 2023 Jun 9:148442. doi: 10.1016/j.brainres.2023.148442.
    PubMed     Abstract available
    
    
    
19. OLIVEIRA LM, Severs L, Moreira TS, Ramirez JM, et al
    Ampakine CX614 increases respiratory rate in a mouse model of Parkinson's disease.
    Brain Res. 2023;1815:148448.
    PubMed     Abstract available
    
    
    
20. ZHOU W, He J, Zhang C, Pan Y, et al
    Fiber-specific white matter alterations in Parkinson's disease patients with freezing of gait.
    Brain Res. 2023 Jun 2:148440. doi: 10.1016/j.brainres.2023.148440.
    PubMed     Abstract available
    
    
    May 2023
21. HENRIQUE BINDA K, Landau AM, Chacur M, Brooks DJ, et al
    Treadmill exercise modulates nigral and hippocampal cannabinoid receptor type 1 in the 6-OHDA model of Parkinson's disease.
    Brain Res. 2023 May 31:148436. doi: 10.1016/j.brainres.2023.148436.
    PubMed     Abstract available
    
    
    
22. ROUZITALAB A, Boulay CB, Sachs AJ
    Volitional Control of Beta Activities in Parkinson's Disease Patients.
    Brain Res. 2023 May 6:148394. doi: 10.1016/j.brainres.2023.148394.
    PubMed     Abstract available
    
    
    April 2023
23. CONTI MAZZA MM, Centner A, Werner DF, Bishop C, et al
    Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats.
    Brain Res. 2023 Apr 29:148381. doi: 10.1016/j.brainres.2023.148381.
    PubMed     Abstract available
    
    
    March 2023
24. BOSCH TJ, Espinoza AI, Singh A
    Cerebellar oscillatory dysfunction during lower-limb movement in Parkinson's disease with freezing of gait.
    Brain Res. 2023;1808:148334.
    PubMed     Abstract available
    
    
    
25. NING B, Wang Z, Wu Q, Deng Q, et al
    Acupuncture inhibits autophagy and repairs synapses by activating the mTOR pathway in Parkinson's disease depression model rats.
    Brain Res. 2023 Mar 11:148320. doi: 10.1016/j.brainres.2023.148320.
    PubMed     Abstract available
    
    
    February 2023
26. MAO S, Teng X, Li Z, Zu J, et al
    Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's Disease.
    Brain Res. 2023 Feb 6:148271. doi: 10.1016/j.brainres.2023.148271.
    PubMed     Abstract available
    
    
    November 2022
27. WANG RF, Li YP, Zhang HY, Xu SS, et al
    Sleep benefit in patients with Parkinson's disease is associated with the dopamine transporter expression in putamen.
    Brain Res. 2022 Nov 29:148173. doi: 10.1016/j.brainres.2022.148173.
    PubMed     Abstract available
    
    
    
28. LIN HC, Wu YH, Huang CW, Ker MD, et al
    Verification of the beta oscillations in the subthalamic nucleus of the MPTP-induced parkinsonian minipig model.
    Brain Res. 2022 Nov 12:148165. doi: 10.1016/j.brainres.2022.148165.
    PubMed     Abstract available
    
    
    October 2022
29. XIE J, Li T, He T, Xu R, et al
    Deep brain stimulation on the external segment of the globus pallidus improves the electrical activity of internal segment of globus pallidus in a rat model of Parkinson's disease.
    Brain Res. 2022 Oct 3:148115. doi: 10.1016/j.brainres.2022.148115.
    PubMed     Abstract available
    
    
    June 2022
30. NI W, Zhou J, Ling Y, Lu X, et al
    Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in Parkinson's disease model.
    Brain Res. 2022;1790:147978.
    PubMed     Abstract available
    
    
    May 2022
31. NAZAROVA L, Liu H, Xie H, Wang L, et al
    Targeting gut-brain axis through Scalp-Abdominal electroacupuncture in Parkinson's disease.
    Brain Res. 2022 May 31:147956. doi: 10.1016/j.brainres.2022.147956.
    PubMed     Abstract available
    
    
    
32. ISHOLA IO, Awogbindin IO, Olubodun-Obadun TG, Oluwafemi OA, et al
    Morin ameliorates rotenone-induced Parkinson disease in mice through antioxidation and anti-neuroinflammation: gut-brain axis involvement.
    Brain Res. 2022 May 30:147958. doi: 10.1016/j.brainres.2022.147958.
    PubMed     Abstract available
    
    
    March 2022
33. LIU SH, Wang YL, Jiang SM, Wan XJ, et al
    Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
    Brain Res. 2022 Mar 9:147879. doi: 10.1016/j.brainres.2022.147879.
    PubMed     Abstract available
    
    
    
34. COGO S, Ho FY, Tosoni E, Tomkins JE, et al
    The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation.
    Brain Res. 2022;1778:147781.
    PubMed     Abstract available
    
    
    February 2022
35. SUN X, Zhang C, Tao H, Yao S, et al
    LINC00943 acts as miR-338-3p sponge to promote MPP(+)-induced SK-N-SH cell injury by directly targeting SP1 in Parkinson's disease.
    Brain Res. 2022 Feb 3:147814. doi: 10.1016/j.brainres.2022.147814.
    PubMed     Abstract available
    
    
    January 2022
36. FRANCELLE L, Mazzulli JR
    Neuroinflammation in Gaucher disease, neuronal ceroid lipofuscinosis, and commonalities with Parkinson's disease.
    Brain Res. 2022;1780:147798.
    PubMed     Abstract available
    
    
    November 2021
37. ARAUJO-SILVA F, Santinelli FB, Felipe I Imaizumi L, Silveira APB, et al
    Temporal dynamics of cortical activity and postural control in response to the first levodopa dose of the day in people with Parkinson's disease.
    Brain Res. 2021 Nov 14:147727. doi: 10.1016/j.brainres.2021.147727.
    PubMed     Abstract available
    
    
    September 2021
38. MEMOU A, Dimitrakopoulos L, Kedariti M, Kentros M, et al
    Defining (and blocking) neuronal death in Parkinson's disease: Does it matter what we call it?
    Brain Res. 2021 Sep 4:147639. doi: 10.1016/j.brainres.2021.147639.
    PubMed     Abstract available
    
    
    August 2021
39. NIELSEN SD, Pearson NM, Seidler K
    The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on alpha-synuclein transport.
    Brain Res. 2021 Aug 6:147609. doi: 10.1016/j.brainres.2021.147609.
    PubMed     Abstract available
    
    
    May 2021
40. ERICSSON M, von Saucken V, Newman AJ, Doehr L, et al
    Crowded organelles, lipid accumulation, and abnormal membrane tubulation in cellular models of enhanced alpha-synuclein membrane interaction.
    Brain Res. 2021;1758:147349.
    PubMed     Abstract available
    
    
    April 2021
41. GAN C, Ma K, Wang L, Si Q, et al
    Dynamic functional connectivity changes in Parkinson's disease patients with REM sleep behavior disorder.
    Brain Res. 2021 Apr 11:147477. doi: 10.1016/j.brainres.2021.147477.
    PubMed     Abstract available
    
    
    March 2021
42. SUBRAHMANIAN N, LaVoie MJ
    Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson's disease? A critical reappraisal.
    Brain Res. 2021 Mar 18:147434. doi: 10.1016/j.brainres.2021.147434.
    PubMed     Abstract available
    
    
    
43. GUILLAUMIN A, Serra GP, Georges F, Wallen-Mackenzie A, et al
    Experimental investigation into the role of the subthalamic nucleus (STN) in motor control using optogenetics in mice.
    Brain Res. 2021;1755:147226.
    PubMed     Abstract available
    
    
    
44. FERNANDEZ-ESPEJO E, Rodriguez de Fonseca F, Suarez J, Martin de Pablos A, et al
    Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson's disease, and correlates with levodopa equivalent daily dose.
    Brain Res. 2021 Mar 4:147411. doi: 10.1016/j.brainres.2021.147411.
    PubMed     Abstract available
    
    
    January 2021
45. VEDAM-MAI V
    Harnessing The Immune System For The Treatment Of Parkinson's Disease.
    Brain Res. 2021 Jan 29:147308. doi: 10.1016/j.brainres.2021.147308.
    PubMed     Abstract available
    
    
    
46. LIU J, Hu H, Wu B
    RIPK1 inhibitor ameliorates the MPP(+)/MPTP-induced Parkinson's disease through the ASK1/JNK signalling pathway.
    Brain Res. 2021 Jan 29:147310. doi: 10.1016/j.brainres.2021.147310.
    PubMed     Abstract available
    
    
    
47. WANG Y, Yao L, Gao S, Zhang G, et al
    Inhibition of striatal dopamine D5 receptor attenuates levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Brain Res. 2021 Jan 7:147266. doi: 10.1016/j.brainres.2020.147266.
    PubMed     Abstract available
    
    
    
48. CRIAUD M, Kim JH, Zurowski M, Lobaugh N, et al
    Anxiety in Parkinson's Disease: Abnormal resting activity and connectivity.
    Brain Res. 2021 Jan 4:147235. doi: 10.1016/j.brainres.2020.147235.
    PubMed     Abstract available
    
    
    
49. ZHOU S, Zhang D, Guo J, Chen Z, et al
    Deficiency of NEAT1 prevented MPP(+)-induced inflammatory response, oxidative stress and apoptosis in dopaminergic SK-N-SH neuroblastoma cells via miR-1277-5p/ARHGAP26 axis.
    Brain Res. 2021;1750:147156.
    PubMed     Abstract available
    
    
    November 2020
50. FERRAZ CRUZ C, Maria Forti Barela A, Dona F, Gracioli Genoves G, et al
    Parkinson's disease delays predictable visual cue processing without affecting complex and unpredictable visual cue processing in postural control.
    Brain Res. 2020 Nov 25:147209. doi: 10.1016/j.brainres.2020.147209.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.